Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Prevalence and clinical characteristics of remission during treatment in generalized anxiety.

Destoop M, van den Eede F, Ansseau M, Albert A, Vanbelle S, Mignon A, Slachmuylders P, Sabbe B.

Int J Psychiatry Clin Pract. 2013 Jun;17(2):90-7. doi: 10.3109/13651501.2013.784789.

PMID:
23485125
2.
3.

Does comorbid subthreshold anxiety predict treatment response in depression? Results from a naturalistic cohort study (the CRESCEND study).

Seo HJ, Song HR, Jeong S, Kim JB, Lee MS, Kim JM, Yim HW, Jun TY.

J Affect Disord. 2014 Jan;152-154:352-9. doi: 10.1016/j.jad.2013.09.037. Epub 2013 Oct 7.

PMID:
24144584
4.

One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample.

Carter RM, Wittchen HU, Pfister H, Kessler RC.

Depress Anxiety. 2001;13(2):78-88.

PMID:
11301924
5.

Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trial.

Pollack MH, Zaninelli R, Goddard A, McCafferty JP, Bellew KM, Burnham DB, Iyengar MK.

J Clin Psychiatry. 2001 May;62(5):350-7. Erratum in: J Clin Psychiatry 2001 Aug;62(8):658.

PMID:
11411817
6.

[Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study)].

Pélissolo A, André C, Chignon JM, Dutoit D, Martin P, Richard-Berthe C, Tignol J.

Encephale. 2002 Nov-Dec;28(6 Pt 1):510-9. French.

PMID:
12506263
7.

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Sep;60(9):580-3.

PMID:
10520975
8.

Remission rates in patients with anxiety disorders treated with paroxetine.

Ballenger JC.

J Clin Psychiatry. 2004 Dec;65(12):1696-707.

PMID:
15641876
9.

Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?

Zimmerman M, Martinez JA, Attiullah N, Friedman M, Toba C, Boerescu DA, Rahgeb M.

J Clin Psychiatry. 2012 Jun;73(6):790-5. doi: 10.4088/JCP.11m07203. Epub 2012 Apr 17.

PMID:
22569085
10.

Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder.

Boylan KR, Bieling PJ, Marriott M, Begin H, Young LT, MacQueen GM.

J Clin Psychiatry. 2004 Aug;65(8):1106-13.

PMID:
15323597
11.

Symptom differences between depressed outpatients who are in remission according to the Hamilton Depression Rating Scale who do and do not consider themselves to be in remission.

Zimmerman M, Martinez J, Attiullah N, Friedman M, Toba C, Boerescu DA.

J Affect Disord. 2012 Dec 15;142(1-3):77-81. doi: 10.1016/j.jad.2012.03.044. Epub 2012 Sep 12.

PMID:
22980402
12.
13.

The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.

Lee JH, Dunner DL.

Depress Anxiety. 2008;25(2):91-7.

PMID:
17311265
14.

[Clinical and therapeutic characteristics of social phobia in French psychiatry (Phoenix study)].

Pélissolo A, Huron C, Fanget F, Servant D, Stiti S, Richard-Berthe C, Boyer P.

Encephale. 2006 Jan-Feb;32(1 Pt 1):106-12. French.

PMID:
16633297
15.

Prevalence and impact of generalized anxiety disorder and major depression in primary care in Belgium and Luxemburg: the GADIS study.

Ansseau M, Fischler B, Dierick M, Mignon A, Leyman S.

Eur Psychiatry. 2005 May;20(3):229-35.

PMID:
15935421
16.

Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review.

Gao K, Muzina D, Gajwani P, Calabrese JR.

J Clin Psychiatry. 2006 Sep;67(9):1327-40. Review.

PMID:
17017818
17.

Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.

Sheehan DV, Harnett-Sheehan K, Spann ME, Thompson HF, Prakash A.

Int Clin Psychopharmacol. 2011 Mar;26(2):75-83. doi: 10.1097/YIC.0b013e328341bb5f.

PMID:
21102344
18.

[The prevalence of generalized anxiety disorder and comorbidity among psychiatric outpatients].

Ozcan M, Uğuz F, Cilli AS.

Turk Psikiyatri Derg. 2006 Winter;17(4):276-85. Turkish.

19.
20.

Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.

Nimatoudis I, Zissis NP, Kogeorgos J, Theodoropoulou S, Vidalis A, Kaprinis G.

Int Clin Psychopharmacol. 2004 Nov;19(6):331-6.

PMID:
15486518

Supplemental Content

Support Center